BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3954382)

  • 1. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
    Neda H; Watanabe N; Sone H; Yamauchi N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H; Itoh N; Tamaya T
    Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
    Watanabe N; Niitsu Y; Yamauchi N; Neda H; Sone H; Urushizaki I; Yamamoto A; Nagamuta M; Sugawara Y
    Immunopharmacol Immunotoxicol; 1988; 10(1):53-65. PubMed ID: 3361071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced gastric cancer showing complete cure by immunochemotherapy with FT-207 and OK-432 confirmed by thorough histologic examination of total gastrectomy matter].
    Futatsuki K; Kanda Y; Shimada S; Ishibashi I; Takemori Y; Izuno O; Suda Y; Fujiwara M; Takubo K; Takayama S
    Gan No Rinsho; 1985 Jun; 31(7):870-6. PubMed ID: 3928945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of unresectable advanced gastric cancer with effective treatment by local administration of OK-432 on operation].
    Kodama M; Taniguchi T; Furukawa H; Takahashi T; Hara T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2301-3. PubMed ID: 2735772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endoscopic intratumor administration of OK-432 in gastric cancer unsuitable for surgery.
    Nakazawa S; Yoshino J; Kijima Y; Yasumasa N; Ohhashi S; Mizutani K
    Endoscopy; 1989 Jul; 21(4):168-71. PubMed ID: 2776702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of cytokine levels in ascitic fluid after intraperitoneal administration of OK-432 or CDDP].
    Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2326-9. PubMed ID: 7944471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
    Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
    J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
    Satomi T; Inoue S; Fujita T; Ogawa S; Honda H; Hayashi M
    Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An autopsied case of an aged patient with advanced gastric cancer that showed a complete response to immunochemotherapy].
    Mizumoto S; Ohoue M; Takami Y; Iihara K; Kurokawa E; Akashi H; Aoki Y; Mori H; Okano K
    Gan No Rinsho; 1989 Dec; 35(15):1791-4. PubMed ID: 2514300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
    Hironaka K; Yamaguchi Y; Okita R; Okawaki M; Nagamine I
    Anticancer Res; 2006; 26(5B):3701-7. PubMed ID: 17094388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells.
    Morisaki T; Matsunaga H; Beppu K; Ihara E; Hirano K; Kanaide H; Mori M; Katano M
    Anticancer Res; 2000; 20(5B):3363-73. PubMed ID: 11131636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
    Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
    Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432].
    Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1443-5. PubMed ID: 8373202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432].
    Mizoguchi T; Katano M; Yamamoto H; Hisatsugu T
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):794. PubMed ID: 3627102
    [No Abstract]   [Full Text] [Related]  

  • 20. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
    Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
    Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.